How do consent forms for diagnostic high‐throughput sequencing address unsolicited and secondary findings? A content analysis

Abstract excerpt

Whole exome and whole genome sequencing are increasingly being offered to patients in the clinical setting. Yet, the question of whether, and to what extent, unsolicited findings (UF) and/or secondary findings (SF) should be returned to patients remains open and little is known about how diagnostic consent forms address this issue. We systematically identified consent forms for diagnostic genomic sequencing...

Topics

Join the communities discussing this publication.

• Biomedical Ethics and Regulation
• Ethics in Clinical Research
• Genomics and Rare Diseases